Kiniksa Pharmaceuticals Stock Statistic Functions Beta

KNSA Stock  USD 22.08  0.24  1.08%   
Kiniksa Pharmaceuticals statistic functions tool provides the execution environment for running the Beta function and other technical functions against Kiniksa Pharmaceuticals. Kiniksa Pharmaceuticals value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Kiniksa Pharmaceuticals statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Kiniksa Pharmaceuticals correlated with the market. If Beta is less than 0 Kiniksa Pharmaceuticals generally moves in the opposite direction as compared to the market. If Kiniksa Pharmaceuticals Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kiniksa Pharmaceuticals is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kiniksa Pharmaceuticals is generally in the same direction as the market. If Beta > 1 Kiniksa Pharmaceuticals moves generally in the same direction as, but more than the movement of the benchmark.

Kiniksa Pharmaceuticals Technical Analysis Modules

Most technical analysis of Kiniksa Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kiniksa from various momentum indicators to cycle indicators. When you analyze Kiniksa charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kiniksa Pharmaceuticals Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kiniksa Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kiniksa Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Kiniksa Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kiniksa Pharmaceuticals's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Kiniksa Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Kiniksa Pharmaceuticals, we also check how macroeconomic factors affect Kiniksa Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Payables Turnover5.956.857.2
Days Of Inventory On Hand167.86200.97137.66
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kiniksa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
19.1222.0224.92
Details
Intrinsic
Valuation
LowRealHigh
21.3624.2627.16
Details
6 Analysts
Consensus
LowTargetHigh
23.1125.4028.19
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.15-0.050.02
Details

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Kiniksa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiniksa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiniksa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiniksa Pharmaceuticals Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kiniksa Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For information on how to trade Kiniksa Stock refer to our How to Trade Kiniksa Stock guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiniksa Pharmaceuticals. If investors know Kiniksa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiniksa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
5.5
Earnings Share
(0.12)
Revenue Per Share
5.415
Quarterly Revenue Growth
0.674
Return On Assets
(0.03)
The market value of Kiniksa Pharmaceuticals is measured differently than its book value, which is the value of Kiniksa that is recorded on the company's balance sheet. Investors also form their own opinion of Kiniksa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiniksa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiniksa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiniksa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiniksa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiniksa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiniksa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.